Eevia Secures New Sales Orders Worth c. KSEK 955 (KEUR 86), Sensing Stronger Demand for High-Quality Bilberry Extracts Across Europe
Eevia Health PLC ("Eevia" or "The Company") has received multiple new sales orders for products totaling KEUR 86 from various European customers.
Eevia Health, a leader in producing premium natural extracts from wild-harvested raw materials, has secured multiple sales orders totaling KEUR 86 (c. KSEK 955). These orders, received from key European customers in Finland and France, as well as a new customer in Sweden, indicate a growing demand for Eevia’s high-quality Feno-Myrtillus™ standardized bilberry extracts, even if Eevia recently has raised prices for its bilberry range.
The recent orders, which are repeat purchases, encompass several grades of Feno-Myrtillus™ and demonstrate the strength of Eevia's established customer relationships. With all products in stock and ready for immediate shipment, the Company is well-positioned to meet customer needs without the delays typically associated with raw material procurement. This further enhances Eevia’s cash flow and supports the achievement of key turnaround targets, e.g., reducing inventory levels.
Eevia anticipates additional orders from these valued customers in the future and remains focused on expanding its presence in Europe and beyond, driven by a growing customer base.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: [email protected] or [email protected]
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses global health challenges with bioactive compounds sustainably extracted from renewable plant materials. It focuses on the gut and related health, including kidney and urinary health.
Eevia Health is a manufacturer of 100% organically certified plant extracts. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally, and these global brands utilize the ingredients in their consumer product formulas.
As a pioneering company, Eevia is developing high-value food ingredients, blended solutions, and biomaterials that significantly benefit human health. Eevia Health operates a modern green-chemistry production facility in Finland with a short value chain and environmentally friendly carbon footprint. Eevia listed its shares at the Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.